Blood And Marrow Transplantation: Clinical Trials

7 trials for Blood And Marrow Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 1, Withdrawn 1
Phase 22Completed 1, Unknown 1
Not applicable1Recruiting 1

Follow Blood And Marrow Transplantation: new trials by email Literature Review of Blood And Marrow Transplantation trials Research Report on Blood And Marrow Transplantation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
Mesenchymal Stem Cells (MSCs) - Blood And Marrow Transplantation, Adult Respiratory Distress Syndrome
Phase 1CompletedM.D. Anderson Cancer Center202017-02-242020-04-10
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
CD34 Positive Stem Cell Infusion, Miltenyi device - Blood And Marrow Transplantation
Not applicableRecruitingM.D. Anderson Cancer Center2002015-05-062026-05-20
Infusion of Allogeneic, 3rd Party CD19-specific T Cells
Cyclophosphamide, Fludarabine, T-Cell Infusion - Blood And Marrow Transplantation, Leukemia
Phase 1WithdrawnM.D. Anderson Cancer Center2014-10-202020-01-22
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative), Fludarabine, Melphalan, ATG (Reduced Intensity) - Blood And Marrow Transplantation, Leukemia
Phase 1 / Phase 2UnknownTargazyme, Inc.252013-11-012013-11-18
Plerixafor for Stem Cell Mobilization in Normal Donors
Filgrastim, Plerixafor, Apheresis Procedure - Blood And Marrow Transplantation
Phase 2CompletedM.D. Anderson Cancer Center222013-10-012019-04-23
Intravesical Cidofovir for Hemorrhagic Cystitis
Cidofovir, Probenecid - Blood And Marrow Transplantation
Phase 1CompletedM.D. Anderson Cancer Center62013-09-012016-12-06
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
Melphalan, Fludarabine, Mycophenolate mofetil - Blood And Marrow Transplantation, Leukemia
Phase 1CompletedM.D. Anderson Cancer Center332012-07-132017-04-28

Narrower conditions

Leukemia (3)  ·  Lymphoma (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Hodgkin Disease (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Myelodysplastic Syndromes (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Cystitis, Hemorrhagic (1)  ·  Hematologic Neoplasms (1)  ·  Histiocytosis, Langerhans-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Bone Marrow Diseases (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Leukemia, B-Cell (2)  ·  Leukemia, Lymphoid (2)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)

Interventions

fludarabine (3)  ·  Busulfan (2)  ·  Clofarabine (2)  ·  Melphalan (2)  ·  Mycophenolic Acid (2)  ·  Rituximab (2)  ·  Tacrolimus (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine phosphate (2)  ·  Antilymphocyte Serum (1)  ·  Blood Component Removal (1)  ·  Blood Specimen Collection (1)  ·  Bone Marrow Purging (1)  ·  Bone Marrow Transplantation (1)  ·  Cidofovir (1)

Sponsors

M.D. Anderson Cancer Center (6)  ·  Targazyme, Inc. (1)

Countries

United States (6)

Top investigators

Elizabeth Shpall, MD (3)  ·  Amanda L. Olson, MD (1)  ·  Chitra M. Hosing, MD (1)  ·  Partow Kebriaei, MD (1)  ·  Roy F. Chemaly, MD, MPH, MBA (1)

Results publications

PMID 25778529, PMID 26612873

NIH funding

P01CA148600 (1)